Wainamics

Executive Summary

Wainamics is a US-based microfluidic product design and development company founded in 2016, headquartered in San Jose, California. The company specializes in developing high-performance microfluidic cartridges and integrated systems for life science and diagnostics customers, accelerating product development from concept to manufacturing scale-up. With expertise in the diagnostics and microbiome sectors, Wainamics enables clients to bring novel microfluidic-based assays and point-of-care devices to market more efficiently. Despite being a private company with no disclosed funding or valuation, Wainamics plays a critical role in the microfluidics supply chain, serving as a design and manufacturing partner for emerging diagnostic platforms. Its focus on scalability and performance positions it well to capture growing demand for microfluidic solutions in precision medicine, infectious disease testing, and microbiome analysis.

Upcoming Catalysts (preview)

• Q4 2026Major Partnership with Diagnostic OEM40% success
• Q2 2026Series A Funding Announcement30% success
• Q1 2027Commercial Launch of Proprietary Microfluidic Platform20% success